Tech Company Financing Transactions
Itero Biopharmaceuticals Funding Round
Itero Biopharmaceuticals, based in Mountain View, secured $21 million in funding from Panorama Capital and SV Health Investors.
Transaction Overview
Company Name
Announced On
6/11/2008
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series A
Investors
Panorama Capital (Lead Investor) (Srinivas Akkaraju)
SV Health Investors (Lead Investor) (Michael Ross)
Proceeds Purpose
The proceeds will be used to fund the initial development of Itero's therapeutic protein pipeline.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
2109 Landings Drive
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
Itero Biopharmaceuticals is focused on developing value-added follow-on and novel therapeutic proteins andantibodies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bryan Lawlis
Chief Financial Officer
Edward Albini
Chief Medical Officer
Darlene Horton
Co-Founder
Jerald Beers
Browse more venture capital transactions:
Prev: 6/10/2008: MovieSet venture capital transaction
Next: 6/11/2008: Bullhorn venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs